NO994365L - Forutsigelse av koronararterie-sykdom - Google Patents
Forutsigelse av koronararterie-sykdomInfo
- Publication number
- NO994365L NO994365L NO994365A NO994365A NO994365L NO 994365 L NO994365 L NO 994365L NO 994365 A NO994365 A NO 994365A NO 994365 A NO994365 A NO 994365A NO 994365 L NO994365 L NO 994365L
- Authority
- NO
- Norway
- Prior art keywords
- coronary artery
- artery disease
- prediction
- methods
- patient
- Prior art date
Links
- 208000029078 coronary artery disease Diseases 0.000 title abstract 6
- 108700028369 Alleles Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 238000001514 detection method Methods 0.000 abstract 2
- 239000012472 biological sample Substances 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 238000005070 sampling Methods 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/545—IL-1
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/813,456 US6210877B1 (en) | 1997-03-10 | 1997-03-10 | Prediction of coronary artery disease |
| PCT/US1998/004725 WO1998040517A1 (en) | 1997-03-10 | 1998-03-09 | Prediction of coronary artery disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO994365D0 NO994365D0 (no) | 1999-09-09 |
| NO994365L true NO994365L (no) | 1999-11-09 |
Family
ID=25212420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO994365A NO994365L (no) | 1997-03-10 | 1999-09-09 | Forutsigelse av koronararterie-sykdom |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6210877B1 (enExample) |
| EP (1) | EP0983381B1 (enExample) |
| JP (2) | JP4250765B2 (enExample) |
| CN (1) | CN100523214C (enExample) |
| AR (1) | AR011943A1 (enExample) |
| AT (1) | ATE370246T1 (enExample) |
| AU (1) | AU738875B2 (enExample) |
| BR (1) | BR9808313A (enExample) |
| CA (1) | CA2282746C (enExample) |
| DE (2) | DE69838250T2 (enExample) |
| DK (1) | DK0983381T3 (enExample) |
| EA (1) | EA199900813A1 (enExample) |
| ES (1) | ES2156843T3 (enExample) |
| GR (1) | GR20010300016T1 (enExample) |
| IL (1) | IL131745A0 (enExample) |
| MX (1) | MXPA99008223A (enExample) |
| NO (1) | NO994365L (enExample) |
| NZ (1) | NZ337642A (enExample) |
| PL (1) | PL335603A1 (enExample) |
| PT (1) | PT983381E (enExample) |
| WO (1) | WO1998040517A1 (enExample) |
| ZA (1) | ZA981937B (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6210877B1 (en) * | 1997-03-10 | 2001-04-03 | Interleukin Genetics, Inc. | Prediction of coronary artery disease |
| US6524795B1 (en) | 1997-03-10 | 2003-02-25 | Interleukin Genetics, Inc. | Diagnostics for cardiovascular disorders |
| US6720141B1 (en) | 1999-11-01 | 2004-04-13 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for restenosis |
| US7820383B2 (en) | 1997-03-10 | 2010-10-26 | Interleukin Genetics, Inc. | Method for diagnosing myocardial infarction |
| US20050282198A1 (en) * | 1997-05-29 | 2005-12-22 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for diseases associated with an IL-1 inflammatory haplotype |
| GB9711040D0 (en) * | 1997-05-29 | 1997-07-23 | Duff Gordon W | Prediction of inflammatory disease |
| US6437216B1 (en) | 1997-11-13 | 2002-08-20 | Interleukin Genetics Inc. | Transgenic models of inflammatory disease |
| GB9723835D0 (en) * | 1997-11-13 | 1998-01-07 | Nicklin Martin | Interleukin knockout |
| US6746839B1 (en) * | 1998-01-12 | 2004-06-08 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for an obstructive airway disease |
| US20050032077A1 (en) * | 1998-03-10 | 2005-02-10 | Duff Gordon W. | Detecting genetic predisposition to sight-threatening diabetic retinopathy |
| US6733967B1 (en) | 1998-04-21 | 2004-05-11 | Interleukin Genetics, Inc. | Fetal testing for prediction of low birth weight |
| WO1999054707A2 (en) * | 1998-04-21 | 1999-10-28 | Interleukin Genetics, Inc. | Fetal testing for prediction of low birth weight |
| US6251598B1 (en) | 1998-10-30 | 2001-06-26 | Interleukin Genetics, Inc. | Methods for diagnosing sepsis |
| JP2003500005A (ja) * | 1999-02-10 | 2003-01-07 | インターリューキン ジェネティックス インコーポレイテッド | ＩＬ−１β遺伝子の突然変異に基づく治療および診断 |
| JP2003500069A (ja) * | 1999-05-24 | 2003-01-07 | インタールーキン ジェネティックス インク | 再狭窄の診断及び治療薬 |
| JP2003508022A (ja) * | 1999-06-30 | 2003-03-04 | インターリューキン ジェネティックス インコーポレイテッド | Ｉｌ−１炎症性ハプロタイプと関連する病気の診断および治療方法 |
| US20030152947A1 (en) * | 2001-06-15 | 2003-08-14 | Crossman David C. | Methods for detecting and treating the early onset of aging-related conditions |
| EP1463745A4 (en) * | 2001-11-19 | 2007-11-07 | Interleukin Genetics Inc | FUNCTIONAL POLYMORPHISMS OF THE INTERLEUKIN-1 SITE AFFECTING TRANSCRIPTION AND SUSCEPTIBILITY TO INFLAMMATORY AND INFECTIOUS DISEASES |
| US20080311581A1 (en) * | 2001-11-19 | 2008-12-18 | David Wyllie | Functional polymorphisms of the interleukin-1 locus affecting transcription and susceptibility to inflammatory and infectious diseases |
| EP1327639A1 (en) * | 2002-01-15 | 2003-07-16 | Bayer Ag | Prediction of cardiovascular disease by genetic polymorphisms in cardiovascular associated genes |
| WO2003064600A2 (en) * | 2002-01-25 | 2003-08-07 | Interleukin Genetics, Inc. | The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes |
| US20070264645A1 (en) * | 2002-01-25 | 2007-11-15 | Kenneth Kornman | IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes |
| BR0314552A (pt) * | 2002-09-30 | 2005-08-09 | Novartis Ag | Métodos para prognosticar elevações de colesterol durante terapia imunossupressora |
| US20050053956A1 (en) * | 2002-11-13 | 2005-03-10 | Dietz Harry C. | Detection of a predisposition for the development of coronary artery disease |
| US20060204962A1 (en) * | 2003-02-03 | 2006-09-14 | Udo Stropp | Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy |
| WO2004081186A2 (en) * | 2003-03-10 | 2004-09-23 | Applera Corporation | Single nucleotide polymorphisms associated with stenosis, methods of detection and uses thereof |
| CA2566257A1 (en) * | 2004-05-07 | 2005-11-24 | Applera Corporation | Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof |
| US7597884B2 (en) | 2004-08-09 | 2009-10-06 | Alios Biopharma, Inc. | Hyperglycosylated polypeptide variants and methods of use |
| US8105775B2 (en) * | 2005-10-25 | 2012-01-31 | Interleukin Genetics, Inc. | IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes |
| RU2310862C1 (ru) * | 2006-05-02 | 2007-11-20 | Государственное образовательное учреждение высшего профессионального образования "Тверская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" | Способ выявления риска развития ишемической болезни сердца |
| US7935498B2 (en) * | 2006-07-07 | 2011-05-03 | Siemens Healthcare Diagnostics Inc. | Methods for identifying patients with increased risk of an adverse cardiovascular event |
| WO2008060627A2 (en) * | 2006-11-15 | 2008-05-22 | Interleukin Genetics, Inc. | The il-1 gene cluster, insulin resistance and coronary artery disease associated polymorphisms and haplotypes and methods of using same |
| US20090170105A1 (en) * | 2007-11-08 | 2009-07-02 | Interleukin Genetics, Inc. | Diagnostics for Aging-Related Dermatologic Disorders |
| US20100112570A1 (en) * | 2008-10-22 | 2010-05-06 | Interleukin Genetics, Inc. | Genetic Markers for Weight Management and Methods of Use Thereof |
| CN102747075B (zh) * | 2012-06-07 | 2014-07-23 | 中国医学科学院阜外心血管病医院 | 与冠心病相关的6号染色体易感区域标签单核苷酸多态性位点及其组成的单体型与应用 |
| CA3011363A1 (en) | 2016-01-12 | 2017-07-20 | Interleukin Genetics, Inc. | Methods for predicting response to treatment |
| CN106202936A (zh) * | 2016-07-13 | 2016-12-07 | 为朔医学数据科技（北京）有限公司 | 一种疾病风险预测方法及系统 |
| US10329620B2 (en) | 2017-01-12 | 2019-06-25 | Cardioforecast Ltd. | Methods and kits for treating cardiovascular disease |
| CA3142662A1 (en) | 2019-06-06 | 2020-12-10 | Sitokine Limited | Compositions and methods for treating lung, colorectal and breast cancer |
| CN110277137B (zh) * | 2019-06-13 | 2022-03-18 | 南方医科大学顺德医院(佛山市顺德区第一人民医院) | 一种用于检测冠心病的基因芯片信息处理系统及方法 |
| WO2021028469A1 (en) | 2019-08-12 | 2021-02-18 | Sitokine Limited | Compositions and methods for treating cytokine release syndrome and neurotoxicity |
| WO2021205013A1 (en) | 2020-04-09 | 2021-10-14 | Sitokine Limited | Compositions and methods for treating covid-19 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5110920A (en) | 1982-01-22 | 1992-05-05 | Cetus Corporation | HLA typing method and DNA probes used therein |
| US4582788A (en) | 1982-01-22 | 1986-04-15 | Cetus Corporation | HLA typing method and cDNA probes used therein |
| US4623619A (en) | 1982-03-03 | 1986-11-18 | Nordisk Insulinlaboratorium | Method for the determination of liability in human individuals to develop atherosclerosis |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5268267A (en) | 1987-08-21 | 1993-12-07 | The General Hospital Corporation | Method for diagnosing small cell carcinoma |
| GB9301453D0 (en) * | 1993-01-26 | 1993-03-17 | Clonit Spa | Nucleotide proves |
| US5658729A (en) | 1994-10-11 | 1997-08-19 | The University Of British Columbia | Method, reagent and kit for evaluating susceptibility to premature atherosclerosis |
| US5686246A (en) | 1995-08-03 | 1997-11-11 | Kornman; Kenneth S. | Detecting genetic predisposition to periodontal disease |
| US5698399A (en) | 1996-04-05 | 1997-12-16 | Duff; Gordon W. | Detecting genetic predisposition for osteoporosis |
| US6210877B1 (en) * | 1997-03-10 | 2001-04-03 | Interleukin Genetics, Inc. | Prediction of coronary artery disease |
-
1997
- 1997-03-10 US US08/813,456 patent/US6210877B1/en not_active Expired - Fee Related
-
1998
- 1998-03-06 ZA ZA9801937A patent/ZA981937B/xx unknown
- 1998-03-09 NZ NZ337642A patent/NZ337642A/en unknown
- 1998-03-09 CA CA002282746A patent/CA2282746C/en not_active Expired - Fee Related
- 1998-03-09 ES ES98910298T patent/ES2156843T3/es not_active Expired - Lifetime
- 1998-03-09 MX MXPA99008223A patent/MXPA99008223A/es unknown
- 1998-03-09 AT AT98910298T patent/ATE370246T1/de not_active IP Right Cessation
- 1998-03-09 WO PCT/US1998/004725 patent/WO1998040517A1/en not_active Ceased
- 1998-03-09 CN CNB988049155A patent/CN100523214C/zh not_active Expired - Fee Related
- 1998-03-09 DK DK98910298T patent/DK0983381T3/da active
- 1998-03-09 DE DE69838250T patent/DE69838250T2/de not_active Expired - Lifetime
- 1998-03-09 AU AU64574/98A patent/AU738875B2/en not_active Ceased
- 1998-03-09 EA EA199900813A patent/EA199900813A1/ru unknown
- 1998-03-09 BR BR9808313-9A patent/BR9808313A/pt not_active Application Discontinuation
- 1998-03-09 PT PT98910298T patent/PT983381E/pt unknown
- 1998-03-09 AR ARP980101032A patent/AR011943A1/es unknown
- 1998-03-09 DE DE0983381T patent/DE983381T1/de active Pending
- 1998-03-09 PL PL98335603A patent/PL335603A1/xx unknown
- 1998-03-09 IL IL13174598A patent/IL131745A0/xx unknown
- 1998-03-09 JP JP53974098A patent/JP4250765B2/ja not_active Expired - Fee Related
- 1998-03-09 EP EP98910298A patent/EP0983381B1/en not_active Expired - Lifetime
-
1999
- 1999-09-09 NO NO994365A patent/NO994365L/no unknown
-
2001
- 2001-04-30 GR GR20010300016T patent/GR20010300016T1/el unknown
-
2008
- 2008-10-29 JP JP2008277752A patent/JP2009077727A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009077727A (ja) | 2009-04-16 |
| EP0983381A1 (en) | 2000-03-08 |
| ES2156843T1 (es) | 2001-08-01 |
| EP0983381B1 (en) | 2007-08-15 |
| CN100523214C (zh) | 2009-08-05 |
| DE69838250T2 (de) | 2008-05-08 |
| EA199900813A1 (ru) | 2000-06-26 |
| PL335603A1 (en) | 2000-05-08 |
| CA2282746A1 (en) | 1998-09-17 |
| ES2156843T3 (es) | 2008-04-16 |
| ATE370246T1 (de) | 2007-09-15 |
| US6210877B1 (en) | 2001-04-03 |
| JP2001514522A (ja) | 2001-09-11 |
| PT983381E (pt) | 2007-11-26 |
| CN1255948A (zh) | 2000-06-07 |
| WO1998040517A1 (en) | 1998-09-17 |
| EP0983381A4 (en) | 2004-05-12 |
| AU6457498A (en) | 1998-09-29 |
| NO994365D0 (no) | 1999-09-09 |
| DK0983381T3 (da) | 2007-12-17 |
| NZ337642A (en) | 2001-02-23 |
| DE69838250D1 (de) | 2007-09-27 |
| CA2282746C (en) | 2009-02-24 |
| MXPA99008223A (es) | 2003-07-21 |
| JP4250765B2 (ja) | 2009-04-08 |
| AU738875B2 (en) | 2001-09-27 |
| IL131745A0 (en) | 2001-03-19 |
| DE983381T1 (de) | 2000-11-09 |
| ZA981937B (en) | 1999-09-06 |
| BR9808313A (pt) | 2000-05-16 |
| AR011943A1 (es) | 2000-09-13 |
| GR20010300016T1 (en) | 2001-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO994365L (no) | Forutsigelse av koronararterie-sykdom | |
| Kriek et al. | Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk | |
| Aho et al. | Epidemiology of rheumatoid arthritis in Finland | |
| NO980439L (no) | Detektering av genetisk predisposisjon for periodontal sykdom | |
| AU5754699A (en) | Detection and determination of the stages of coronary artery disease | |
| Alvarez et al. | Components of biological variation of biochemical markers of bone turnover in Paget’s bone disease | |
| WO2004046729A3 (en) | Bodily fluid markers of tissue hypoxia | |
| ATE319105T1 (de) | Nmr-verfahren zur bestimmung des risikos zur entwicklung von diabetes type 2 | |
| NO20050186L (no) | Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser | |
| ES2162361T3 (es) | Metodos, kits y reactivos mejorados para el muestreo de defectos de la coagulacion sanguinea. | |
| US20090011452A1 (en) | Method of Prognosis of Mental Diseases, E.G. Autism and Cerebral Palsy | |
| SI1682907T1 (sl) | Postopek identifikacije subjekta ki mu grozi nevarnost srčne odpovedi z ugotavljanjem nivoja galaktina ali trombospondina | |
| ATE524557T1 (de) | Verbreiteter polymorphismus in scn5a, einhergehend mit durch medikamente induzierte herzarrythmien | |
| EP1276771A4 (en) | Sensitive detection of wild-type and mutant egfr by specific elisa assays in any biological sample | |
| ATE314648T1 (de) | Diagnostisches verfahren für asthma | |
| ATE139803T1 (de) | Allelische verbindung des humanen dopamin- (d2)rezeptor-gens in kompulsionsstörungen wie alkoholismus | |
| ATE155689T1 (de) | Aktivätsmessungen des amylin | |
| US8148091B2 (en) | Detection of chronic kidney disease patients or coronary artery disease using bone morphogenic protein-4 | |
| DE69912453D1 (de) | Verfahren und materialien zur diagnose instabiler angina | |
| FI951778A0 (fi) | Menetelmä allergian toteamiseksi | |
| Kujovich et al. | Factors V Leiden and the prothrombin gene mutation: two common genetic defects associated with thrombosis | |
| Kanttz et al. | New state markers for alcoholism. Comparison of carbohydrate deficient transferrin (CDT) and alcohol mediated (triantennary) transferrin (AMT) | |
| ES2225849T3 (es) | Metodo para probar la capacidad inmunologica. | |
| NO20082394L (no) | Polypeptidmarkor for diagnostikk og vurdering av vaskulaere sykdommer | |
| EP1666612A3 (fr) | Procédé de détermination de l'activité d'une substance mettant en oeuvre un test fonctionnel in vitro |